"FDA approved" labeling statement
The American Pharmaceutical Assn. asked Sen. Hatch (R-Utah) in Aug. 20 letter for his support of an amendment to the FD&C Act that would require a drug mfr. to include the word "FDA" followed by an NDA number in Rx labeling. APhA said the term would indicate a drug had gone through the approval process but would not mislead consumers as would the term "FDA approved." The assn. maintained that "an indication of FDA approval status would constitute a governmental 'commercial' endorsement of a drug product".
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The International Medical Device Regulators Forum, perhaps most notorious for its efforts to standardize audit processes between nations with its Medical Device Single Audit Program, is also focusing on harmonizing device reviews and adverse event codes.
Dr Reddy’s Laboratories has become the third Revlimid ANDA sponsor to settle patent litigation action with Bristol Myers Squibb’s Celgene. However, the Indian company will join Alvogen in not being able to launch before first settler Natco, which has partnered with Teva’s Watson.